Quick Answer
Medtronic plc reported Total Revenue of $33.54 billion for fiscal year 2025.
Medtronic plc — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $33.54B +3.6% |
$32.36B +3.6% |
$31.23B -1.4% |
$31.69B +5.2% |
$30.12B +4.2% |
$28.91B -5.4% |
| Revenue (ASC 606) | $33.54B +3.6% |
$32.36B +3.6% |
$31.23B -1.4% |
$31.69B +5.2% |
$30.12B +4.2% |
$28.91B -5.4% |
| Net Income | $4.66B +26.8% |
$3.68B -2.2% |
$3.76B -25.4% |
$5.04B +39.7% |
$3.61B -24.7% |
$4.79B +3.4% |
| Diluted EPS | $3.61 +30.8% |
$2.76 -2.1% |
$2.82 -24.4% |
$3.73 +40.2% |
$2.66 -24.9% |
$3.54 +3.8% |
| Total Assets | $91.68B +1.9% |
$89.98B -1.1% |
$90.95B -0.0% |
$90.98B -2.3% |
$93.08B +2.6% |
$90.69B +1.1% |
| Cash and Equivalents | $2.22B +72.7% |
$1.28B -16.8% |
$1.54B -58.5% |
$3.71B +3.4% |
$3.59B -13.2% |
$4.14B -5.8% |
| Stockholders Equity | $48.02B -4.4% |
$50.21B -2.5% |
$51.48B -2.0% |
$52.55B +2.2% |
$51.43B +1.4% |
$50.74B +1.3% |
| Operating Income | $5.96B +15.8% |
$5.14B -6.2% |
$5.49B -4.6% |
$5.75B +28.3% |
$4.48B -6.4% |
$4.79B -23.6% |
| Shares Outstanding | 1.28B -2.2% |
1.31B -1.5% |
1.33B +0.0% |
1.33B -1.1% |
1.35B +0.3% |
1.34B +0.0% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | January 31, 2026 | $9.02B | +8.7% | +0.6% |
| Revenue (ASC 606) | January 31, 2026 | $9.02B | +8.7% | +0.6% |
| Net Income | January 31, 2026 | $1.14B | -11.7% | -16.8% |
| Diluted EPS | January 31, 2026 | $0.89 | -11.9% | -16.8% |
| Total Assets | January 31, 2026 | $91.48B | +1.7% | +0.2% |
| Cash and Equivalents | January 31, 2026 | $1.15B | -7.5% | -10.5% |
| Stockholders Equity | January 31, 2026 | $48.98B | -0.8% | +0.7% |
| Operating Income | January 31, 2026 | $1.46B | -11.1% | -13.2% |
| Shares Outstanding | January 31, 2026 | 1.28B | +0.0% | +0.1% |
- Medtronic plc reported Total Revenue of $33.54 billion for fiscal year 2025.
- Medtronic plc showed an increase of +3.6% in Total Revenue compared to the prior fiscal year.
- Medtronic plc reported Revenue (ASC 606) of $33.54 billion for fiscal year 2025.
- Medtronic plc showed an increase of +3.6% in Revenue (ASC 606) compared to the prior fiscal year.
- Medtronic plc reported Net Income of $4.66 billion for fiscal year 2025.
- Medtronic plc showed an increase of +26.8% in Net Income compared to the prior fiscal year.
- Medtronic plc reported Diluted EPS of $3.61 per share for fiscal year 2025.
- Medtronic plc showed an increase of +30.8% in Diluted EPS compared to the prior fiscal year.
- Medtronic plc reported Total Assets of $91.68 billion for fiscal year 2025.
- Medtronic plc showed an increase of +1.9% in Total Assets compared to the prior fiscal year.
- Medtronic plc reported Cash and Equivalents of $2.22 billion for fiscal year 2025.
- Medtronic plc showed an increase of +72.7% in Cash and Equivalents compared to the prior fiscal year.
- Medtronic plc reported Stockholders Equity of $48.02 billion for fiscal year 2025.
- Medtronic plc showed a decrease of -4.4% in Stockholders Equity compared to the prior fiscal year.
- Medtronic plc reported Operating Income of $5.96 billion for fiscal year 2025.
- Medtronic plc showed an increase of +15.8% in Operating Income compared to the prior fiscal year.
- Medtronic plc reported Shares Outstanding of 1.28 billion shares for fiscal year 2025.
- Medtronic plc showed a decrease of -2.2% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: